Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Itron (ITRI) Research & Development (2016 - 2025)

Historic Research & Development for Itron (ITRI) over the last 17 years, with Q4 2025 value amounting to $53.1 million.

  • Itron's Research & Development fell 897.11% to $53.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $134.0 million, marking a year-over-year decrease of 3769.03%. This contributed to the annual value of $207.0 million for FY2025, which is 371.71% down from last year.
  • Itron's Research & Development amounted to $53.1 million in Q4 2025, which was down 897.11% from $26.2 million recorded in Q3 2025.
  • Over the past 5 years, Itron's Research & Development peaked at $58.3 million during Q4 2024, and registered a low of $25.9 million during Q1 2025.
  • Moreover, its 5-year median value for Research & Development was $49.7 million (2021), whereas its average is $47.0 million.
  • Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 1887.69% in 2023, then plummeted by 5052.58% in 2025.
  • Over the past 5 years, Itron's Research & Development (Quarter) stood at $49.9 million in 2021, then fell by 6.48% to $46.6 million in 2022, then rose by 15.64% to $53.9 million in 2023, then rose by 8.2% to $58.3 million in 2024, then fell by 8.97% to $53.1 million in 2025.
  • Its Research & Development was $53.1 million in Q4 2025, compared to $26.2 million in Q3 2025 and $28.8 million in Q2 2025.